Intrinsiqs

Is Clinuvel Pharmaceuticals Ltd. overvalued?

Clinuvel Pharmaceuticals Ltd. (CUVL) — key valuation metrics and fundamentals.

No verdict
Price
$4.95
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$249.9M
Dividend yield
0.6%
Return on equity
—
Sector
Healthcare

See the full interactive analysis →

Fair value compares CUVL's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.